Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Margaret Akinhanmi"'
Autor:
Margaret Akinhanmi, Joyce E. Balls-Berry, Suliman El-Amin, Jennifer Geske, Colin Colby, Christi Patten, Joanna Biernacka, Mark A. Frye
Publikováno v:
Journal of Clinical and Translational Science, Vol 2, Pp 74-74 (2018)
OBJECTIVES/SPECIFIC AIMS: Learning Objectives of this session: Identify possible reasons for misdiagnosis of bipolar patients of African ancestry by reviewing differences in symptom presentation between African American (AA) and European American (EA
Externí odkaz:
https://doaj.org/article/044eb55336964c93be2759e077f0b6de
Autor:
Eric J. Vallender, Mark A. Frye, Bipolar Genome Study, Suliman El-Amin, John R. Kelsoe, Joanna M. Biernacka, Joyce E. Balls-Berry, Jennifer R. Geske, Brandon J. Coombes, Mark E. Ladner, Margaret Akinhanmi
Publikováno v:
Journal of Affective Disorders. 260:361-365
Misdiagnosis is common in bipolar disorder and disproportionally affects racial and ethnic minorities. There is interest in better understanding the contribution of differential symptomatic illness presentation to misdiagnosis.Utilizing the Genetic A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd56712809457211e3703fe405cf6ff7
https://doi.org/10.1016/j.jad.2019.09.022
https://doi.org/10.1016/j.jad.2019.09.022
Autor:
Heshan Liu, James N. Ingle, Abigail Thomas, Judy C. Boughey, Jenna Lilyquist, Judith A. Gilbert, David W. Hillman, Krishna R. Kalari, Margaret Akinhanmi, Fergus J. Couch, Mei Yin C. Polley, Minetta C. Liu, Roberto A. Leon-Ferre, Ahmed Elkhanany, Daniel W. Visscher, Vivian Negron, Matthew P. Goetz, Victoria Cafourek
Publikováno v:
Breast Cancer Research and Treatment. 167:89-99
Given its high recurrence risk, guidelines recommend systemic therapy for most patients with early-stage triple-negative breast cancer (TNBC). While some clinicopathologic factors and tumor-infiltrating lymphocytes (TILs) are known to be prognostic i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af9ad4aa5f16b1feb7fda893a72d6a3a
https://doi.org/10.1007/s10549-017-4499-7
https://doi.org/10.1007/s10549-017-4499-7
Autor:
Jenna Lilyquist, Jill S. Dolinsky, Rachel McFarland, David E. Goldgar, Chunling Hu, Holly LaDuca, Eric C. Polley, Margaret Akinhanmi, Hermela Shimelis, Fergus J. Couch, Jie Na
Publikováno v:
Cancer Research. 77:P5-09
Clinical genetic testing of individuals with a personal or family history of breast and ovarian cancer using panels for BRCA1/2 and other candidate cancer predisposition genes has become routine clinical practice. Several of the genes on hereditary c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c71d98029a54562fd353ba44b06bdcee
https://doi.org/10.1158/1538-7445.sabcs16-p5-09-03
https://doi.org/10.1158/1538-7445.sabcs16-p5-09-03
Autor:
Keith F. Decker, Margaret Akinhanmi, Kyle L. Jung, Jeremy Hoog, César Sánchez, Nathan D. VanderKraats, James I. McDonald, John R. Edwards, Jeffrey F. Hiken, Lisa E. Rois, Matthew J. Ellis
Publikováno v:
Oncogene
Approximately 75% of breast cancers express estrogen receptor α (ERα) and depend on estrogen signals for continued growth. Aromatase inhibitors (AIs) prevent estrogen production and inhibit estrogen receptor signaling, resulting in decreased cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea873e3478e3561b9a5b3631cac325e
https://doi.org/10.1038/onc.2016.397
https://doi.org/10.1038/onc.2016.397
Autor:
Margaret Akinhanmi, Brigette Tippin Davis, Priyanka Sharma, Drakoulis Yannoukakos, Eric C. Polley, Raymond Moore, David E. Goldgar, Peter A. Fasching, Jill S. Dolinsky, Abigail Thomas, Heli Nevanlinna, Judy Garber, Diana Eccles, Hiltrud Brauch, Andrew K. Godwin, Bing Jian Feng, Holly LaDuca, Angela Cox, Song Yao, Hermela Shimelis, Jie Na, Florentia Fostira, Steven N. Hart, Fergus J. Couch, Tina Pesaran, Amanda Ewart-Toland, Chunling Hu, Jenna Lilyquist, Irene Konstantopoulou
Publikováno v:
JNCI Journal of the National Cancer Institute
Background\ud Germline genetic testing with hereditary cancer gene panels can identify women at increased risk of breast cancer. However, those at increased risk of triple-negative (estrogen receptor–negative, progesterone receptor–negative, huma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb12160fb9f3ea88ca976366ab9061cc
https://eprints.soton.ac.uk/426063/
https://eprints.soton.ac.uk/426063/
Publikováno v:
Plastic and Reconstructive Surgery. 144:513e-514e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26f12a5aaea33b42faa24e375b8d6adc
https://doi.org/10.1097/prs.0000000000005967
https://doi.org/10.1097/prs.0000000000005967
Publikováno v:
Archives of Gynecology and Obstetrics. 300:485-486
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82a92435b79f0b7c745be61b2bb39971
https://doi.org/10.1007/s00404-019-05099-8
https://doi.org/10.1007/s00404-019-05099-8
Autor:
Felicia V. Caples, Eric J. Vallender, Joanna M. Biernacka, Joyce E. Balls-Berry, Mark E. Ladner, Margaret Akinhanmi, Mark A. Frye
Publikováno v:
European Neuropsychopharmacology. 29:S232
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::400c931f3b948b4f3a350302691f3697
https://doi.org/10.1016/j.euroneuro.2019.08.225
https://doi.org/10.1016/j.euroneuro.2019.08.225
Autor:
Jeremy Hoog, James I. McDonald, Kyle L. Jung, John R. Edwards, César Sánchez, Keith F. Decker, Nathan D. VanderKraats, Matthew J. Ellis, Jeffrey F. Hiken, Margaret Akinhanmi
Approximately 75% of breast cancers express estrogen receptor α (ERα) and depend on estrogen signals for continued growth. Aromatase inhibitors (AIs) prevent estrogen production and inhibit estrogen receptor signaling, resulting in decreased cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e4a7ca661e4d829786a36e0e22167f
https://doi.org/10.1101/056770
https://doi.org/10.1101/056770